Press releases

Advanced Search
  • May 5, 2014
    Third quarter revenue increased 7 percent to $968 million, driven by continued growth in the company's Procedural Solutions segment

    SAN DIEGO, May 5, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its third quarter of fiscal 2014, ended...

  • May 2, 2014

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 39(th) Annual Health Care Conference on...

  • May 1, 2014
    - Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014,...

  • Apr 24, 2014
    Also Introduces the pink Achieve® Breast Biopsy Device

    SAN DIEGO, CA, March 24, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, launched its new AVAflex ® Vertebral Balloon System today at the 39th annual Scientific...

  • Apr 24, 2014
    Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings

    BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSPresto(TM) Near Patient CD4...

  • Apr 22, 2014
    CareFusion Technology Receives Top Marks for Quality, Ease of Use and Reliability

    SAN DIEGO, April 22, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that nurses have ranked the Pyxis MedStation® system as the #1...

  • Apr 9, 2014
    BD MAX™ GC rt PCR Assay Receives CE Mark

    BALTIMORE, MD, April 09, 2014 – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the CE mark and launch of the BD...

  • Apr 7, 2014

    SAN DIEGO, April 7, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release third quarter fiscal 2014 results on Monday, May 5, following the close of trading on...

  • Apr 3, 2014

    BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2014 earnings conference call on Thursday, May 1, 2014, at 8:00 a.m....

  • Apr 1, 2014
    Designed Exclusively for CareFusion by Surgical Site Solutions, Inc.

    SAN DIEGO, CA, April 1, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced availability of the ClipVac® hair removal system from Surgical Site Solutions,...

  • Mar 24, 2014
    Global Expert on Infectious Disease and Public Health

    FRANKLIN LAKES, N.J., March 24, 2014 – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced the election of Dr. Claire Pomeroy to its Board of...

  • Mar 19, 2014
    CareFusion Places in Top 10 for Overall Software Vendor Rankings

    SAN DIEGO, CA, Feb. 19, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced its MedMined® Surveillance Advisor was named the Category Leader...

  • Mar 19, 2014
    BD Veritor(TM) System for Rapid Detection of RSV Receives 510(k) Clearance and CLIA Waiver

    BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory...

  • Mar 6, 2014
    V. Mueller Bipolar Instruments Promote Improved Safety for Electrosurgical Procedures

    SAN DIEGO,CA, March 6, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the global launch of a new line of electrosurgical instruments...

  • Feb 25, 2014
    BD Veritor(TM) System for Rapid Detection of Group A Strep Receives 510(k) Clearance and CLIA Waiver

    BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory...

  • Feb 18, 2014
    Infusion pump interoperability collaboration with CareFusion and Cerner wins award for Improving the Patient Experience: Care and Safety

    SAN DIEGO, CA and KANSAS CITY, MO, Feb. 18, 2014 /PRNewswire/ – The RFID in Healthcare Consortium (RHCC) and IntelligentHospital.org today announced that Children's Hospitals and Clinics of...

  • Feb 14, 2014

    BALTIMORE, MD, February 14, 2014 – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that the company has achieved...

  • Feb 11, 2014
    BD and USAID Collaborate to Support National TB Program Capacity Building and Development Goals

    SURABAYA, February 11, 2014 – In an ongoing effort to prevent and control infectious disease outbreaks globally, the U.S. Agency for International Development (USAID) and Becton, Dickinson and...

  • Feb 7, 2014

    FRANKLIN LAKES, N.J., February 7, 2014 – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President,...

  • Feb 7, 2014

    BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2014:...

  • Feb 4, 2014
    -- Raises the bottom end of full fiscal year 2014 revenue and earnings ranges for guidance.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.0 billion for the first fiscal quarter ended December 31, 2013,...

  • Feb 3, 2014
    Second quarter revenue increased to $922 million, driven by continued strength in the company's Procedural Solutions segment

    SAN DIEGO, CA, Feb. 3, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its second quarter of fiscal 2014,...

  • Jan 29, 2014
    CareFusion, Terumo Sign Distribution Agreement For IV Catheters

    SAN DIEGO, CA, Jan. 29, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, and Terumo Corporation, the largest medical technology company in Japan, today...

  • Jan 28, 2014

    The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on March 31, 2014 to holders of record on March...

  • Jan 14, 2014

    BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 28,...